Feb 2026 $33 M No. 5 $10 to $50 million 22
Thrombolex, Inc.: Raise no. 5, Feb 2026 × Investors in this round 22 investors had bought by the notice of Mar 12, 2026: 22 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $33 M of $51 M offered; $18 M still to sell
Smallest investment taken no minimum stated
What was sold equity, other: Includes Conversion of Outstanding Notes Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice John J. Cerminaro · Executive Officer Marvin J. Woodall · Executive Officer, Director Michael J. Cerminaro · Executive Officer, Director Clay A. DeMarcus · Director David A. Bonita · Director Keegan A. Harper · Director Paul A. Stewart · Director Sam A. Liang · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John Cerminaro, Cfo. Source: SEC Form D, newest notice filed Mar 12, 2026. Read the notice at the SEC .
equity SEC Jun 2024 $1 M No. 4 Under $2 million 5
Thrombolex, Inc.: Raise no. 4, Jun 2024 × Investors in this round 5 investors had bought by the notice of Jun 21, 2024: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $5 M offered; $4 M still to sell
Smallest investment taken $50,000
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice John A. Cerminaro · Executive Officer Michael J. Cerminaro · Executive Officer, Director Tony J. Litwiller · Executive Officer Kelly A. Elliott · Director Marvin J. Woodall · Director Paul A. Stewart · Director Todd A. Richmond · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Total Offering amount may be increased by the Issuer”Signed by John Cerminaro, Cfo. Source: SEC Form D, newest notice filed Jun 21, 2024. Read the notice at the SEC .
debt, options SEC Jun 2023 $5 M No. 3 $2 to $10 million 56
Thrombolex, Inc.: Raise no. 3, Jun 2023 × Investors in this round 56 investors had bought by the notice of May 28, 2024: 56 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice John A. Cerminaro · Executive Officer Michael J. Cerminaro · Executive Officer, Director Tony J. Litwiller · Executive Officer Kelly A. Elliott · Director Marvin J. Woodall · Director Paul A. Stewart · Director Todd A. Richmond · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John Cerminaro, Cfo. Source: SEC Form D, newest notice filed May 28, 2024. Read the notice at the SEC .
equity SEC Jul 2022 $2 M No. 2 $2 to $10 million 50
Thrombolex, Inc.: Raise no. 2, Jul 2022 × Investors in this round 50 investors had bought by the notice of Aug 30, 2022: 50 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Brian G. Firth · Executive Officer, Director John A. Cerminaro · Executive Officer Marvin J. Woodall · Executive Officer, Director Michael J. Cerminaro · Executive Officer, Director Paul A. Stewart · Director Todd A. Richmond · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John Cerminaro, Cfo. Source: SEC Form D, newest notice filed Aug 30, 2022. Read the notice at the SEC .
equity SEC Nov 2021 $5 M No. 1 $2 to $10 million 46
Thrombolex, Inc.: Raise no. 1, Nov 2021 × Investors in this round 46 investors had bought by the notice of Nov 29, 2021: 46 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Brian G. Firth · Executive Officer, Director John A. Cerminaro · Executive Officer Marvin J. Woodall · Executive Officer, Director Michael J. Cerminaro · Executive Officer, Director Paul A. Stewart · Director Todd A. Richmond · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John Cerminaro, Cfo. Source: SEC Form D, newest notice filed Nov 29, 2021. Read the notice at the SEC .
equity SEC